Cytokinetics inc news
WebFeb 28, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response ... Web12 hours ago · Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cytokinetics (CYTK – Research Report) and Neurocrine (NBIX – Research Report). TipRanks has tracked 36,000 ...
Cytokinetics inc news
Did you know?
WebMar 16, 2024 · Cytokinetics, Incorporated Common Stock (CYTK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebMar 31, 2024 · (Reuters) -Cytokinetics Inc said on Friday it would focus on its heart disease treatment after its amyotrophic lateral sclerosis (ALS) drug failed a late-stage study. The drug developer's move to employ resources freed up from the ALS project for its potential billion-dollar-plus heart drug sent its shares up more than 5%. Cytokinetics' …
WebMar 27, 2024 · Report Highlights Company Commitment to Patient Centricity, Sustainability, Ethics, Diversity, Equity and Inclusion. SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the release of its inaugural Corporate Responsibility Report, outlining the Company's … WebApr 7, 2024 · Latest Cytokinetics, Inc. Stock News. As of April 06, 2024, Cytokinetics, Inc. had a $3.4 billion market capitalization, putting it in the 78th percentile of companies in the Biotechnology & Medical Research industry. Cytokinetics, Inc. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. ...
WebCytokinetics Inc. is discontinuing its late-stage study of a drug aimed at amyotrophic lateral sclerosis, the potentially deadly neuromuscular condition commonly known as Lou … WebMar 31, 2024 · March 31 (Reuters) - Cytokinetics Inc (CYTK.O) said on Friday it would focus on its heart disease treatment after its amyotrophic lateral sclerosis (ALS) drug …
WebFeb 28, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and …
WebDec 20, 2024 · Under the terms of the License Agreement, Cytokinetics will receive from Ji Xing an upfront and near-term milestone payments of $50 million. Cytokinetics may be eligible to receive from Ji Xing additional milestone payments totaling up to $330 million for the achievement of certain commercial milestone events with respect to the Product. In … port chester clerks officeWebApr 10, 2024 · Cytokinetics, Incorporated. SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced … irish rail drogheda to dublinWebMar 31, 2024 · Cytokinetics, Inc. (CYTK) stock is trading at $35.08 as of 3:32 PM on Friday, Mar 31, a rise of $0.87, or 2.53% from the previous closing price of $34.21. The stock has traded between $34.70 and $36.66 so far today. Volume today is above average. port chester colonyWebApr 10, 2024 · The MarketWatch News Department was not involved in the creation of this content. SOUTH SAN FRANCISCO, Apr 10, 2024 (GLOBE NEWSWIRE via COMTEX) -- SOUTH SAN FRANCISCO, Calif., April 10, 2024 ... irish rail dublin to ennisWebApr 10, 2024 · SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 22 nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2024 at 10:00 … port chester colony grillWebDec 13, 2024 · Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. ... Endpoints News — Cytokinetics nabs Chinese partner, up to $450M as CV becomes company focus . irish rail dublin to arklowport chester commercial real estate